Project Grant H8G47989

This $4,052,881 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program will enable the Massachusetts Department of Public Health (MDPH) to strengthen vaccine-preventable disease prevention and response efforts across the state. The award, effective July 1, 2025 through June 30, 2030, will support MDPH's comprehensive public health services, including disease surveillance, vital statistics data...

This $5,044,422 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program supports the Virginia State Board of Health's Office of Emergency Preparedness Division in delivering a range of public health initiatives focused on immunization of children and adults, prevention of vaccine-preventable diseases, immunization information systems (IIS) data collection and analysis, and pandemic response. The...

The City of New York, through its Department of Health and Mental Hygiene (Health Dept), has been awarded a $6,109,724.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program. The award, effective July 1, 2025, aims to strengthen vaccine-preventable disease prevention and response in New York City over a 5-year period ending on June 30, 2030. The Immunization Cooperative Agreements program supports...

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This Cooperative Agreement award, provided by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program, is intended to strengthen vaccine-preventable disease prevention and response efforts. The $3,487,652 award, with a performance period from July 1, 2025 to June 30, 2030, was granted to the Indiana Department of Health (IDOH), a state government entity. Through this funding, IDOH will...

This Cooperative Agreement award of $33,002 from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268) is intended to strengthen immunization access and confidence in American Samoa. The award, effective July 1, 2025 through June 30, 2030, will be administered by the American Samoa Department of Health, the territory's primary public health agency. The funding will support the department's comprehensive public health initiatives,...

This Project Grant award from the National Science Foundation (CFDA 47.075 - Social, Behavioral, and Economic Sciences program) provides $375,000 to the National Opinion Research Center (NORC) to conduct a community-engaged study examining the role of social media influencers in addressing vaccine information integrity. The key products and services to be delivered include: Using social listening tools to collect, code, and analyze social media posts and comments about a new respiratory...

The Department of Health in the State of Hawaii was awarded a $5,358,220 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program. The goal of this one-year award, effective January 17, 2025 through January 16, 2026, is to increase vaccination rates in Hawaii, with a focus on educating and providing vaccine coverage to populations disproportionately affected by...

This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 - Child Health and Human Development Extramural Research - supports the development and testing of the "Presumptively Initiating Vaccines and Optimizing Talk for Inpatients (PIVOT-IN)" intervention. The $220,000 award will be used to engage hospital stakeholders to design the PIVOT-IN intervention, which has two components: 1) a standardized screening...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $1,508,718.00 Cooperative Agreement to the West Virginia State Health Department under the Immunization Cooperative Agreements (CFDA 93.268) program. The award, effective July 1, 2025 through June 30, 2030, will support the establishment and maintenance of preventive health service programs to immunize individuals against vaccine-preventable diseases, including measles, rubella,...